Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 May 11;302(6785):1149. doi: 10.1136/bmj.302.6785.1149

Pituitary growth hormone and Creutzfeldt-Jakob disease.

M E Macario, M Vaisman, A Buescu, V Moura Neto, H M Araujo, C Chagas
PMCID: PMC1669802  PMID: 2043794

Full text

PDF

Page 1149

1149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchanan C. R., Preece M. A., Milner R. D. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991 Apr 6;302(6780):824–828. doi: 10.1136/bmj.302.6780.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Croxson M., Brown P., Synek B., Harrington M. G., Frith R., Clover G., Wilson J., Gajdusek D. C. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology. 1988 Jul;38(7):1128–1130. doi: 10.1212/wnl.38.7.1128. [DOI] [PubMed] [Google Scholar]
  3. Harrington M. G., Merril C. R., Asher D. M., Gajdusek D. C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 1986 Jul 31;315(5):279–283. doi: 10.1056/NEJM198607313150502. [DOI] [PubMed] [Google Scholar]
  4. Marzewski D. J., Towfighi J., Harrington M. G., Merril C. R., Brown P. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology. 1988 Jul;38(7):1131–1133. doi: 10.1212/wnl.38.7.1131. [DOI] [PubMed] [Google Scholar]
  5. Moura Neto V., Mallat M., Jeantet C., Prochiantz A. Microheterogeneity of tubulin proteins in neuronal and glial cells from the mouse brain in culture. EMBO J. 1983;2(8):1243–1248. doi: 10.1002/j.1460-2075.1983.tb01576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES